Alan Hruza
Impact in
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
- Biophysics top 5%
Papers in
-
- Melanoma and MAPK Pathways 3
- Receptor Mechanisms and Signaling 3
- Phosphodiesterase function and regulation 3
- Oncology 7
- Cancer-related Molecular Pathways 5
- Co-authors
- Paul Reichert (4 shared papers)Thierry Fischmann (5 shared papers)Satwant K. Narula (1 shared paper)Andrew Prongay (1 shared paper)Daniel Lundell (1 shared paper)Charles A. Lunn (1 shared paper)James Fossetta (1 shared paper)Paul P. Trotta (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (10 papers)Journal of Medicinal Chemistry (2 papers)Molecular Cancer Therapeutics (1 paper)Tetrahedron Letters (1 paper)Microscopy and Microanalysis (1 paper)
- Partner nations
- United StatesUkraineUnited Kingdom
In The Last Decade
Alan Hruza
22 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Biochemistry 87
- Biophysics 62
- Physiology 266
- Structural Biology 14
- Molecular Biology 650
Countries citing papers authored by Alan Hruza
This map shows the geographic impact of Alan Hruza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Hruza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Hruza more than expected).
Fields of papers citing papers by Alan Hruza
This network shows the impact of papers produced by Alan Hruza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Hruza. The network helps show where Alan Hruza may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Hruza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 374 | |
| 2 | 1996 | 191 | |
| 3 | 2018 | 165 | |
| 4 | 2018 | 81 | |
| 5 | 2007 | 46 | |
| 6 | 2011 | 43 | |
| 7 | 2016 | 39 | |
| 8 | 2014 | 38 | |
| 9 | 2010 | 34 | |
| 10 | 2007 | 29 | |
| 11 | 2011 | 28 | |
| 12 | 2016 | 25 | |
| 13 | 2012 | 20 | |
| 14 | 1993 | 19 | |
| 15 | 2013 | 17 | |
| 16 | 2001 | 14 | |
| 17 | 2012 | 9 | |
| 18 | 2009 | 8 | |
| 19 | 2009 | 8 | |
| 20 | 2018 | 4 |
About Alan Hruza
Alan Hruza is a scholar working on Molecular Biology, Oncology, Cell Biology, Organic Chemistry and Pharmacology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (5 papers), Cancer-related Molecular Pathways (5 papers), Melanoma and MAPK Pathways (3 papers), Receptor Mechanisms and Signaling (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Click Chemistry and Applications (3 papers), Phosphodiesterase function and regulation (3 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Biochemistry (87 citations), Biophysics (62 citations), Physiology (266 citations), Structural Biology (14 citations) and Molecular Biology (650 citations). Alan Hruza has collaborated with scholars based in United States, Ukraine and United Kingdom. Frequent co-authors include Paul Reichert, Thierry Fischmann, Satwant K. Narula, Andrew Prongay, Daniel Lundell, Charles A. Lunn, James Fossetta, Paul P. Trotta, Leigh J. Walter and Mark R. Walter. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Molecular Cancer Therapeutics, Tetrahedron Letters and Microscopy and Microanalysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.